文献速递心力衰竭与心肌病

远程监测在家庭心衰管理中的应用

Remote Monitoring for Heart Failure Management at Home.
PubMed 文献 · J Am Coll Cardiol · 2023-01-01

综述指出,早期体重和症状远程监测未减少心衰住院,但有助于识别有效监测项目的关键步骤。高危及低危患者需不同信号特性,基于充盈压或肺水含量的淤血监测对减少住院影响最大,需优化算法个性化并关注数字鸿沟。

要点

  • 早期体重和症状远程监测未显著降低心衰住院率
  • 充盈压或肺水含量监测对减少住院影响最大
  • 需个性化算法阈值并解决数字健康公平性问题

核心结论

  • 早期体重和症状远程监测未减少心衰住院,但为有效监测项目提供了方向。
  • 减少住院影响最大的是基于心脏充盈压或肺水含量的淤血监测。

研究设计与样本

  • 综述,检索范围未明确报告。

主要发现

  • 早期体重和症状远程监测未降低心衰住院。
  • 充盈压或肺水含量监测对减少住院影响最大。
  • 植入式节律设备的多参数评分可识别风险增加的患者。

临床怎么用

  • 高危患者需准确、可操作且具早期重评估反应动力学的信号。
  • 低危患者监测的信号规格不同。
  • 算法需个性化信号阈值和干预措施。
  • 远程护理平台应整合多种技术并赋权患者。
  • 需弥合数字鸿沟和心衰护理团队可及性差距。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Early telemonitoring of weights and symptoms did not decrease heart failure hospitalizations but helped identify steps toward effective monitoring programs. A signal that is accurate and actionable with response kinetics for early re-assessment is required for the treatment of patients at high risk, while signal specifications differ for surveillance of low-risk patients. Tracking of congestion with cardiac filling pressures or lung water content has shown most impact to decrease hospitalizations, while multiparameter scores from implanted rhythm devices have identified patients at increased risk. Algorithms require better personalization of signal thresholds and interventions. The COVID-19 epidemic accelerated transition to remote care away from clinics, preparing for new digital health care platforms to accommodate multiple technologies and empower patients. Addressing inequities will require bridging the digital divide and the deep gap in access to HF care teams, who will not be replaced by technology but by care teams who can embrace it.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Stevenson, Ross, Rathman, et al. Remote Monitoring for Heart Failure Management at Home. J Am Coll Cardiol. 2023. PMID: 37286258. doi:10.1016/j.jacc.2023.04.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。